Dr. Gerald Diaz @GeraldMD
31.1M 13.9K 7.3K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
76 results
treatment hivaids opportunistic prevention dosing table pain drugs indications pami tuberculosis antibiotics diabetes diagnosis endocrinology asthma coronavirus hydroxychloroquine therapy antimicrobials
IDSA Aspergillosis Treatment • Invasive pulmonary aspergillosis (IPA) • CNS aspergillosis • Cardiac Aspergillus infection •
IDSA Aspergillosis ... of eye Infectious ... Aspergillosis #Treatment #management ... #pharmacology # ... IDSA
Drugs Used for the Treatment of COVID-19 Infection LOPINAVIR / RITONAVIR INTERFERON Beta-I REMDESIVIR HYDROXYCHLOROQUINE TOCILIZUMAB Piotr Okupski @PiotrOkupski - Original Infographic
the Treatment of COVID ... -19 Infection LOPINAVIR ... smfarmhosp_smfh #Drugs #Medications ... #Pharmacology # ... Table #Management
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications: Agent, Initiation Dose and Max Dosages -
Assessment and Management ... Neuropathic Pain Medications ... Agent, Initiation Dose ... #Pain #Pharmacology ... #Doses #Dosing
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... A and B virus infection ... A virus (HAV) infection ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
Doses of Antituberculosis Drugs for Adults and Children - IDSA First-line drugs: • Isoniazid • Rifampin •
Doses of Antituberculosis ... and Children - IDSA ... Tuberculosis #Drugs #Medications ... #management #pharmacology
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020 #Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Treatment Agents for COVID ... 2020 #Drugs #Medications ... #Treatment #COVID19 ... #Pharmacology # ... Table #Management
COVID-19: ICU Guidelines for the Non-Intensivist Infection Control Risk Factors for Severe Disease Initial Laboratory Workup COVID-19 Specific Medications Respiratory Cardiac Hematologic Neuro/Sedation #COVID19 #ICU
COVID-19: ICU Guidelines ... Non-Intensivist Infection ... Laboratory Workup COVID ... -19 Specific Medications ... NonIntensivist #diagnosis #management
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle • Mixed infections • Streptococcus
IDSA Treatment of ... Necrotizing Infections ... fasciitis #Skin #IDSA ... #Treatment #management ... #antibiotics #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... A and B virus infection ... A virus (HAV) infection ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19 IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... correlate with severe COVID ... respiratory tract infection ... #Pharmacology # ... Management #Medications
empty